Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: SOP for Calculating Signal-to-Noise Ratio – V 2.0

Posted on By

Analytical Method Development: SOP for Calculating Signal-to-Noise Ratio – V 2.0

Standard Operating Procedure for Calculating Signal-to-Noise Ratio in Analytical Method Development


Department Analytical Method Development
SOP No. SOP/AMD/377/2025
Supersedes SOP/AMD/377/2022
Page No. Page 1 of 13
Issue Date 01/06/2025
Effective Date 03/06/2025
Review Date 01/06/2027

1. Purpose

This SOP describes the method for calculating the signal-to-noise ratio (S/N) to evaluate the sensitivity of chromatographic methods. The S/N ratio is critical in defining the limit of

detection (LOD) and limit of quantification (LOQ) during method validation in the analytical method development process.

2. Scope

This procedure applies to the calculation of signal-to-noise ratio in HPLC, UPLC, and GC systems used in the Analytical Method Development department. It is applicable during method development, validation, verification, and routine analysis where sensitivity of detection is to be established or monitored.

3. Responsibilities

  • Analyst: Responsible for acquiring chromatographic data and calculating S/N ratio using instrument software or manual methods.
  • Team Leader: Verifies the calculated values and ensures protocol compliance.
  • QA Personnel: Ensures completeness and regulatory compliance of documentation and calculations.
See also  Analytical Method Development: Pathogen Detection Method Development - V 2.0

4. Accountability

The Head – Analytical Method Development is accountable for the proper implementation, training, and adherence to this SOP within the department.

5. Procedure

5.1 Understanding Signal-to-Noise Ratio

  1. Signal: The height or area of the peak corresponding to the analyte.
  2. Noise: The baseline fluctuation observed in a blank injection or adjacent to the analyte peak.
  3. The S/N ratio provides insight into the method’s ability to distinguish a low-level signal from background noise.

5.2 Equipment and Materials

  1. Validated chromatographic system (HPLC, UPLC, GC)
  2. Chromatography data software (e.g., Empower, Chromeleon, LabSolutions)
  3. Test solution containing the analyte near LOD/LOQ concentration
  4. Blank solution or mobile phase

5.3 Data Acquisition

  1. Inject a suitable low-concentration analyte solution (ideally at LOD/LOQ).
  2. Set integration parameters to ensure proper baseline assignment.
  3. Ensure noise is calculated over a representative segment of baseline close to the analyte peak (same retention time window).
  4. Record the following:
    • Peak height (or area) of the analyte
    • Baseline noise measurement
See also  Analytical Method Development: Precipitation Reaction Based Method Development - V 2.0

5.4 S/N Ratio Calculation Methods

  1. Automated Software Method:
    • Use the software’s inbuilt S/N calculation function.
    • Set the time window and noise calculation method (e.g., ASTM, EP, USP).
    • Record results generated by the software in the S/N worksheet (Annexure-1).
  2. Manual Method:
    • S/N = Height of analyte peak / Amplitude of baseline noise.
    • Measure noise from a blank injection or a segment without peaks near the retention time of the analyte.

5.5 Criteria for Evaluation

  • LOD is typically determined when S/N is ≥ 3
  • LOQ is typically determined when S/N is ≥ 10

5.6 Documentation

  1. Record all calculations in the Signal-to-Noise Calculation Sheet (Annexure-1).
  2. Attach chromatograms with marked peak and noise segments.
  3. Review and approval should be documented in the QA-approved method validation report.

5.7 Deviation Handling

  1. In case of inconsistency in S/N values or unexpected baseline fluctuation, investigate for:
    • Instrumental noise
    • Environmental disturbances
    • Mobile phase impurities or degassing issues
  2. Document deviations and initiate CAPA as per internal deviation SOP.

6. Abbreviations

  • S/N: Signal-to-Noise Ratio
  • LOD: Limit of Detection
  • LOQ: Limit of Quantification
  • HPLC: High Performance Liquid Chromatography
  • GC: Gas Chromatography
  • QA: Quality Assurance
See also  Analytical Method Development: SOP for Line Clearance Check Method Development - V 2.0

7. Documents

  1. Annexure-1: Signal-to-Noise Calculation Worksheet
  2. Annexure-2: S/N Chromatogram Annotation Template

8. References

  • ICH Q2(R1) – Validation of Analytical Procedures
  • USP General Chapter <1058> – Analytical Instrument Qualification
  • 21 CFR Part 211.160 – Laboratory Controls

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name Ravi Menon Sneha Kulkarni Dr. Aditi Sharma
Designation Method Development Analyst QA Reviewer Head – AMD
Department Analytical Method Development Quality Assurance Analytical Method Development

11. Annexures

Annexure-1: Signal-to-Noise Calculation Worksheet

Injection ID Analyte Peak Height Noise S/N Ratio
SAMPLE-001 Drug A 1.15 0.11 10.45

Annexure-2: S/N Chromatogram Annotation Template

Attach chromatogram with visual annotations indicating noise region and signal peak for reference and review purposes.

Revision History

Revision Date Revision No. Details Reason Approved By
01/06/2025 2.0 Revised to include manual and automated calculation steps Annual SOP Review Dr. Aditi Sharma
20/06/2022 1.0 Initial Issue New SOP QA Head
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Analytical Method Development: SOP for Performing Solution Stability Studies – V 2.0
Next Post: Analytical Method Development: SOP for Estimating Detection Limit Using Slope and SD Method – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version